Cardiac Interventions

CHAPTER 18


Cardiac Interventions



The conventional diagnostic angiographic techniques used to demonstrate the anatomy of the heart have already been discussed in Chapter 12. In this chapter we will discuss some of the interventional techniques that are in use today. Interventional cardiology primarily focuses on several major areas: hemodynamic studies, techniques to improve the flow of blood to the myocardium, techniques to improve valve performance, extraction techniques (biopsies, foreign body removal), and electrophysiologic procedures. The techniques for transseptal left-sided heart catheterization as well as hemodynamic measurements have also been discussed in Chapter 12. These techniques can be considered as diagnostic rather than therapeutic (interventional).


Cardiac catheterization is a specialty area that is used for the diagnosis, assessment, and treatment of abnormalities of the heart and great vessels. The procedures are accomplished with standard angiographic catheterization techniques. They are relatively safe and, as we have already seen, may be used as diagnostic studies to determine the nature of the anatomy and any pathology and in conjunction with interventional procedures to effect a nonsurgical treatment.



PERCUTANEOUS CORONARY INTERVENTIONS


Coronary artery disease results from a buildup of plaque in the vessels supplying the heart muscle with blood. This is referred to as the stenosis or narrowing of the vessel lumen. Coronary bypass surgery is the invasive method for treatment of this disease. The process of plaque buildup is no different in the heart than it is in any of the vessels that we have already discussed in previous chapters. The development of percutaneous interventional techniques and selective and subselective catheterization equipment has made percutaneous coronary interventional cardiology possible.



Percutaneous Transluminal Angioplasty


Percutaneous transluminal angioplasty is the interventional technique of enlarging the lumen of a stenosed vessel. Three methods are used to recanalize the vessel: balloon angioplasty, balloon angioplasty with stent placement, and transluminal atherectomy. The procedural technique for the three methods is similar. The thoracic aorta is catheterized using the transfemoral approach and an arterial sheath catheter. The guiding sheath is placed in the orifice of the intended coronary artery, and a guide wire is introduced through it into the coronary artery. The guide wire is passed through the area of stenosis, and the angioplasty catheter is placed across the stenotic area. The method may vary slightly depending upon the type of catheter system that is used.


The angioplasty catheter can be a simple balloon catheter arrangement or a balloon-stent catheter system. The delivery system for the angioplasty catheter will be either over the guide wire or fixed guide wire system. Once the balloon is determined to be in the correct position, it is inflated a number of times. The inflation can last from several seconds to minutes. This action has the result of compressing the plaque against the lumen wall, restoring the flow of blood through the vessel. The expansion of the balloon has the effect of stretching and weakening the vessel wall. Some of the elasticity of the vessel is lost; however, after a period of time the diameter of the vessel lumen can shrink, causing restenosis. This is referred to as “recoil.” The restenosis caused by this phenomenon can be reduced by the use of the balloon-stent system because the stent provides additional support for the arterial wall.


The balloon-stent, as its name implies, has the balloon encased in a metallic stent. The process is slightly different from the balloon catheter alone. The initial expansion of the plaque is usually accomplished by means of a separate balloon catheter, which is subsequently removed once the amount of compression has been achieved and replaced by a “stent over balloon” catheter. When this catheter is placed in the expanded lumen and the balloon is inflated, the stent is compressed into the plaque, providing a firmer support for the compressed plaque. The stent remains in place and the deflated balloon catheter can be removed, leaving a patent vessel (Fig. 18-1). Another type of stent is the self-expanding stent. This type of stent is mounted over the catheter and held in a compressed state by a sheath or membrane. When placed in the area of stenosis the covering sheath or membrane can be removed, allowing the stent to expand to its full diameter. This type of stent is held in place by means of its own expansion force against the vessel wall. Figure 18-2 illustrates the placement of a typical self-expanding stent.




Restenosis of the vessel is possible with either system; however, stents have the added advantage of supporting the vessel wall in cases in which the expanding balloon may have caused it to be weakened. The newer “drug eluting” stent systems show promise in reducing the incidence of restenosis of the vessel. As discussed in Chapter 17, these stents are coated with certain drugs that reduce the incidence of restenosis.


Transluminal atherectomy has already been discussed in Chapter 17. Atherectomy, also referred to as “debulking,” has the advantage over simple transluminal angioplasty of accomplishing the physical removal of the plaque from the artery. This would decrease the probability of rapid restenosis of the vessel. The procedure has some drawbacks. Among these is the relative size of the catheter system compared to angioplasty. Atherectomy systems are much larger and therefore require a larger access sheath. This fact can increase the potential for severe complications in certain at risk patients. This procedure is best utilized in cases in which the vessel lumen is larger or the stenosis is confined to the vessel orifice. Atherectomy is generally not the method of choice and is rarely applied today in the recanalization of stenotic vessels.



Percutaneous Balloon Valvuloplasty


Percutaneous balloon valvuloplasty is similar to the procedure previously described in percutaneous transluminal angioplasty. The difference is that angioplasty is used to repair stenotic vessels and valvuloplasty is used to repair heart valves that are poorly functioning due to stenosis and scarring. The scarring of the valve leaflets cause it to open incompletely, restricting the flow of blood. When the valve is compromised the heart works harder to push the blood through the stenosed valve. There is also a buildup of pressure in the pulmonary circulation due to the backup of blood which can lead to dyspnea. As the scarring progresses it fuses the leaflets at the point where they touch, increasing the narrowing and exacerbating the symptoms. Some symptoms of compromised valve function include dyspnea accompanied by wheezing or coughing, hemoptysis, fluid retention in the lower extremities or lungs, cardiomegaly, atrial fibrillation or other irregular heart rhythms, thrombosis, stroke, and possibly death from severe heart failure.


The point at which the leaflets of the valve fuse is referred to as a “commissure,” and the repair procedure is commonly called a “commissurotomy.” The process causes a breaking of the bond holding the valve leaflets and allows it to operate in a much improved fashion. Originally the repair methods included surgical separation of the leaflets via open heart surgery or valve replacement with a mechanical or animal (pig) valve. In most cases percutaneous valvuloplasty will eliminate the necessity for surgical intervention. Valvuloplasty is commonly employed when there is stenosis of the mitral valve; however, it is also used to relieve tricuspid valve stenosis, aortic valve stenosis, and pulmonary stenosis as well as some congenital valvular diseases.


The procedure is similar to that discussed for percutaneous angioplasty and heart catheterization. The balloon expansion technique is used to achieve repair of the valve. The route of the catheterization varies depending on the valve that is to be repaired.



Percutaneous Balloon Mitral Valvuloplasty


The mitral valve must be accessed from an antegrade position via a transseptal approach to facilitate the valvuloplasty. The catheter can be inserted either in an upper extremity vein or more commonly through the femoral vein. Once in the right atrium the catheter is passed through an interatrial opening (either naturally occurring or created and enlarged enough to admit the catheter). If the opening between the atria must be created, a Brockenbrough needle is used and dilation of the opening is accomplished using a tapered dilator. Measurements of the cardiac output are made using the thermodilution or green dye dilution methods once the catheter is in the left atrium.


A specially designed “Inoue balloon catheter” is usually used for the procedure. The catheter is made from polyvinyl chloride with a balloon at its distal end. The balloon has a latex band around its center so that it restricts the inflation of the center of the balloon. When it is fully inflated it will resemble an hourglass shape (Fig. 18-3).



Once the opening into the left atrium has been accomplished and dilated, the deflated Inoue catheter is placed in the atrial chamber. The distal end is expanded, and the catheter is allowed to float across the valve opening. Additional inflation is applied, the proximal end begins to expand, and the balloon engages the valve. When the balloon resembles an hourglass the catheter is in place across the valve and ready for the valvuloplasty. The balloon is expanded further against the valve to complete the procedure (Fig. 18-4).




Percutaneous Balloon Aortic Valvuloplasty


The principle behind this procedure is the same as in percutaneous balloon mitral valvuloplasty as previously described. A balloon catheter passed through the aortic valve is used to achieve commissural separation. The catheter is passed retrograde from a peripheral artery. The most common route is via the femoral artery; however, in cases of severe peripheral vascular disease the brachial route can be used. If the upper extremity approach is required, smaller diameter catheters are generally used.


The balloon catheter is passed through the aorta and across the aortic valve. The dilation process is accomplished using several different size catheters in succession, gradually increasing their size through the procedure. It is important that the patient’s cardiac rhythm be monitored, and pressure measurements should also be observed during the inflation portion of the procedure. The objective of the procedure is to reduce the pressure gradient between the left ventricle and the aorta to below 30 mm Hg, with a corresponding increase in the diameter of the aortic valve.




Complications of Percutaneous Valvuloplasty


The complications of this procedure are varied and can range from a mild vasovagal reaction to death. The possibility that the procedure will not provide the patient with any mitigation of the stenosis as well as the possibility of restenosis are risks attendant with this procedure. The following list is a summary of some of the complications that can be the result of percutaneous valvuloplasty.





Catheter Ablation


Ablation is a general term referring to the process of destroying and removing tissue. This procedure is commonly accomplished using radiofrequency waves. There are several different energy sources that can be used for catheter ablation besides radiofrequency energy. These include direct electrical stimulation, microwave, laser, cryoablation, ultrasound (US), and chemical. Box 18-1 summarizes the type of energy used and its effect on tissue.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 27, 2016 | Posted by in GENERAL RADIOLOGY | Comments Off on Cardiac Interventions

Full access? Get Clinical Tree

Get Clinical Tree app for offline access